PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 US$
0,00%
(0,00) 1K
12-okt, 10:22:09 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoPTKFY tikeri uchun statistika yaratilmoqda...
Bozor kapitali
31,60 trln
Oʻrtacha hajm
1,94 ming
Hajmi
1,43 ming
52 haftalik eng yuqori
16,36 US$
52 haftalik eng past
7,63 US$
Beta
0,09
Muomaladagi aksiyalar
234,07 mln
Xodimlar soni
13 ming
Bozor kapitali
31,60 trln
Oʻrtacha hajm
1,94 ming
Hajmi
1,43 ming
52 haftalik eng yuqori
16,36 US$
52 haftalik eng past
7,63 US$
Beta
0,09
Muomaladagi aksiyalar
234,07 mln
Xodimlar soni
13 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 kun oldin
Buyback plans and results shaped Kalbe Farma stock review
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
PT Kalbe Farma Unsponsored Indonesia ADR haqida